Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/897c1421d763409b9b5cd4b0353c9706 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|